We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PRCT market cap is 4.24B. The company's latest EPS is USD -2.0293 and P/E is -40.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 35.1M | 43.58M | 44.54M | 53.35M | 58.37M |
| Operating Income | -25.61M | -29.56M | -27.65M | -26.83M | -22.43M |
| Net Income | -24.62M | -27.5M | -25.96M | -25.63M | -20.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.17M | 7.72M | 34.47M | 75.01M | 136.19M |
| Operating Income | -43.55M | -47.8M | -54.16M | -80.72M | -109.17M |
| Net Income | -41.98M | -53.02M | -59.85M | -87.15M | -105.9M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 421.13M | 404.72M | 382.9M | 374.35M | 374.14M |
| Total Liabilities | 121.77M | 123.97M | 118.85M | 122.57M | 132.92M |
| Total Equity | 299.36M | 280.75M | 264.05M | 251.78M | 241.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62M | 125.97M | 337.02M | 309.33M | 404.72M |
| Total Liabilities | 32.76M | 65.01M | 69.93M | 112.26M | 123.97M |
| Total Equity | -143.84M | -182.89M | 267.09M | 197.07M | 280.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -83.21M | -108M | -32.29M | -48.02M | -66.82M |
| Investing | -16.49M | -25.21M | -1.95M | -2.99M | -3.24M |
| Financing | 164.93M | 167.8M | 2.59M | 7.88M | 9.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -43.82M | -48.34M | -57.33M | -80.38M | -108M |
| Investing | 43.15M | -233k | -592k | -2.65M | -25.21M |
| Financing | 26.53M | 106.77M | 262.12M | 3.61M | 167.8M |
| Market Cap | 4.24B |
| Price to Earnings Ratio | -40.05 |
| Price to Sales Ratio | 31.14 |
| Price to Cash Ratio | 16.49 |
| Price to Book Ratio | 15.11 |
| Dividend Yield | - |
| Shares Outstanding | 52.18M |
| Average Volume (1 week) | 668.41k |
| Average Volume (1 Month) | 550.15k |
| 52 Week Change | 93.35% |
| 52 Week High | 103.8099 |
| 52 Week Low | 39.48 |
| Spread (Intraday) | 10.21 (11.22%) |
| Company Name | PROCEPT BioRobotics Corporation |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.procept-biorobotics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
